2000
DOI: 10.1002/(sici)1098-2795(200004)55:4<452::aid-mrd14>3.0.co;2-s
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Oct-4: Control of totipotency and germline determination

Search citation statements

Order By: Relevance

Paper Sections

Select...
185
25
17
7

Citation Types

3
90
1
1

Year Published

2000
2000
2026
2026

Publication Types

Select...
195
23
5
3

Relationship

2
224

Authors

Journals

citations

Cited by 225 publications

(95 citation statements)
references

References 42 publications

3
90
1
1
Order By: Relevance
How this paper cites the one you are viewing
“…GST-Oct-4 and various truncation products were coupled to glutathione-Sepharose beads and tested for their abilities to trap Ets-2 that had been labeled with [ 35 S]methionine by in vitro translation. As expected, 35 S-labeled Ets-2 did form a complex with full-length GST-Oct-4 (Fig. 6A).…”
Section: Results
supporting
confidence: 85%
How this paper cites the one you are viewing
“…GST-Oct-4 and various truncation products were coupled to glutathione-Sepharose beads and tested for their abilities to trap Ets-2 that had been labeled with [ 35 S]methionine by in vitro translation. As expected, 35 S-labeled Ets-2 did form a complex with full-length GST-Oct-4 (Fig. 6A).…”
Section: Results
supporting
confidence: 85%
How this paper cites the one you are viewing
“…Next, we used the FAIMS (-35V)-DIA datasets to assess the efficiency of neuronal differentiation efficacy in KOLF2.1J-derived Neurons (Supplemental Table S2). As expected, protein expression of pluripotency and neural precursor markers POU5F1 (OCT4) (Pesce & Scholer, 2000), PODXL (TRA-1-60) (Draper et al, 2002;Henderson et al, 2002), and SOX2 (Botquin et al, 1998;Ellis et al, 2004) were significantly reduced at the early stage of neuron differentiation (Fig. 5A).…”
Section: Temporal Proteomic Profiling Of Ipsc-derived Neurons
supporting
confidence: 80%
How this paper cites the one you are viewing
“…Oct4, a transcriptional factor, has been suggested as an embryonic stem cell marker 4. Although one study showed Oct4 gene expression in human tumors but not in normal somatic tissues 5, we found that Oct4 nuclear expression is strongly associated with benign lesions but not prostate cancer.…”
Section: Discussion
contrasting
confidence: 64%